Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Sales (2020 - 2025)

Historic Return on Sales for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 0.12%.

  • Burning Rock Biotech's Return on Sales rose 1500.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year increase of 6300.0%. This contributed to the annual value of 0.65% for FY2024, which is 5600.0% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Return on Sales is 0.12%, which was up 1500.0% from 0.06% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Return on Sales registered a high of 0.06% during Q2 2025, and its lowest value of 2.0% during Q2 2022.
  • Its 5-year average for Return on Sales is 1.1%, with a median of 1.32% in 2023.
  • Per our database at Business Quant, Burning Rock Biotech's Return on Sales plummeted by -9100bps in 2021 and then surged by 11100bps in 2023.
  • Burning Rock Biotech's Return on Sales (Quarter) stood at 1.72% in 2021, then grew by 13bps to 1.49% in 2022, then increased by 11bps to 1.32% in 2023, then soared by 58bps to 0.56% in 2024, then surged by 78bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.06% for Q2 2025, and 0.1% during Q1 2025.